Mah Holidays looks expensive at Rs 300/sh: Dipan Mehta

Published on Mon, Jun 29, 2009 at 16:11 |  Source : CNBC-TV18

Updated at Tue, Jun 30, 2009 at 17:16  

Like this story, share it with millions of investors on M3
0
0
Share on Tumblr

Mahindra Holidays fixed IPO price at Rs 300 a share. Dipan Mehta, Member, BSE/NSE said even at Rs 300 a share, it looked expensive. He was more comfortable at slightly lower levels, maybe around Rs 220-230 levels, which would be a good entry point for this company.

Here is a verbatim transcript of Member, BSE/NSE, Dipan Mehta's comments on CNBC-TV18. Also watch the accompanying video.

Mahindra Holidays is a great company. But even at Rs 300 a share we thought it was a bit expensive. I think what was a bit disappointing was that for the last fiscal, which is FY09, then growth rates were quite disappointing. They were flat to lower profits, which mean that this business also is not immune to all the vagaries of the economy and the consumer spending habits."

He added, "To have such a business being discounted at such a high price-earnings multiple was a bit discomforting. Maybe it is one of its kinds, maybe a bit of a concept stock. Therefore, you could see this kind of a pricing. And maybe the stock could trade slightly higher on listing. But I think we are more comfortable at slightly lower levels, maybe around Rs 220-230 levels, which would be a good entry point for this company.

  

More on Moneycontrol

Trending News

Business News

6 ways to backup mobile data
Forget the IIP: there's free cash oozing out of every pore "Forget the IIP: there's free cash oozing out of every pore "

DLF Says Macro Environment Unfavourable W/High Comm & Labour Inflation

The latest earning numbers FIRST on CNBC-TV18
Videos

Feb 10 2012, 21:39

Tulsian buys steel stocks; negative on sugar, ADAG

- in MARKET OUTLOOK

Feb 10 2012, 21:39

Truck demand sluggish; margins down 80bps: Shriram Trans

- in Results Boardroom

Interviews

Feb 10 2012, 15:43 | Source: CNBC-TV18

Growth in margins sustainable going forward: Shasun Pharma  

Feb 10 2012, 15:35 | Source: CNBC-TV18

Expect Q4 GRMs to be similar to Q3: BPCL  

Subscribe to

Moneycontrol Newsletters

Moneycontrol.com offers you a choice of various sectoral and other newsletters for FREE!

Follow moneycontrol.com